|Principal Name||Timothy Counihan, MD|
|Contact Name||Tammy Bator, LPN, CCRC|
|Title||Study to Prevent Incisional Infections among Colorectal Surgery Patients with a new Topical Solution|
|Description||Wound infections can occur in approximately 12-25% of patients undergoing colorectal surgery despite routine efforts to prevent them. |
This study is being done to assess the safety and ability of an experimental drug called E-101 Solution (study drug), in addition to routine efforts, to prevent incisional wound infection for 30 days after your colorectal surgery.
|Inclusion/Notes||- Scheduled to undergo elective colon and/or rectal surgical procedures involving an open laparotomy incision|
Male or female =18 years of age.
If female, is non-pregnant (negative pregnancy test result at the Screening/Randomization Visit) and non-lactating.
5. If female, is either not of childbearing potential (defined as postmenopausal for at least 1 year or surgically sterile
|Current Trial Type||Enrolling|